Le Lézard
Classified in: Science and technology
Subjects: Photo/Multimedia, Contract/Agreement, Product/Service

SEQSTER and Audacity Health Partner to Accelerate Clinical Trial Recruitment for Pharma Sponsors


SEQSTER PDM Inc. ("SEQSTER"), the leading patient-centric healthcare technology company today announced a strategic partnership with Audacity Health, a renowned digital branding and patient recruitment company at the 2024 Healthcare Information and Management Systems Society (HIMSS) Annual Conference and exhibition. This powerful alliance will significantly enhance SEQSTER's digital marketing and patient engagement capabilities, fueling broader awareness and accelerating enrollment in life-changing clinical trials and studies.

Audacity Health will provide a comprehensive suite of services to amplify SEQSTER's digital presence and accelerate patient recruitment:

"Our partnership with Audacity Health empowers patients to take the first step towards participating in potentially life-altering clinical trials. By making it easier to find and understand relevant studies, we're removing barriers to progress in medical research, ultimately helping bring new treatments to those who need them," stated Ardy Arianpour, CEO & Co-Founder of SEQSTER.

"Teaming up with SEQSTER allows us to combine their cutting-edge technology with our digital strategies to the forefront of clinical research. This partnership is about empowering patients to improve recruitment and accelerate medical breakthroughs through data collection and sharing," said Jill Collins, CEO of Audacity Health.

This marks a turning point in patient engagement for clinical trials. SEQSTER and Audacity Health are positioned to transform healthcare by making research more accessible and patient-centered.

ABOUT SEQSTER

SEQSTER is the leading healthcare technology company that breaks down health data silos at scale. Its enterprise operating system aggregates disparate health data sources into a single, 360-degree view of a patient in real-time, solving a multitude of challenges for life sciences, patient engagement and data interoperability.

SEQSTER has nationwide coverage of EHRs from hospitals and medical groups, genomic DNA, wearables, pharmacy and social determinants of health data. Through its customizable white-label approach, SEQSTER provides accelerated access to de-identified, tokenized, real-time data and comprehensive curated data to address critical needs across the healthcare continuum.

SEQSTER is privately held and headquartered in San Diego.

To learn more about SEQSTER, please contact us at [email protected] or visit www.seqster.com.

ABOUT AUDACITY HEALTH

Audacity is a brand strategy + activation agency that builds powerful brands by sparking emotions because we ensure the human element is central to everything we create. Our integrated brand strategy and activation solutions help our health and science clients become market leaders.

Our proprietary solutions help our clients successfully create and launch new brands, refresh or reposition existing brands, and create and deploy campaigns that shift perceptions and generate results.

Our branding capabilities extend all the way from the corporate level down to a single product level.

We serve clients across the whole continuum of health + science, including both startups and Fortune 500 companies focused on:

For more information about Audacity Health, please visit www.audacityhealth.com.


These press releases may also interest you

at 06:05
Revvity, Inc. , today reported financial results for the first quarter ended March 31, 2024. The Company reported GAAP earnings per share of $0.21, as compared to $4.50 in the same period a year ago. GAAP revenue for the quarter was $650 million,...

at 06:05
Vena, the Complete Planning platform loved by finance and trusted by business, today announced that tickets for Excelerate Finance 2024, the premier annual conference for finance, operations and business leaders, have sold out. The event will be held...

at 06:05
TOPseven, a leading developer of renewable energy technology, is launching its latest innovation, the TOP7 LPS 2.0, at CleanPower 2024. Situated at booth number 3220, TOPseven will showcase a state-of-the-art product designed to transform Lightning...

at 06:00
Theravance Biopharma, Inc. will report its first quarter 2024 financial results and provide a business update after market close on Monday, May 13, 2024. An accompanying conference call and simultaneous webcast will be hosted at 5:00 pm ET (2:00 pm...

at 06:00
Repertoire® Immune...

at 06:00
Ernst & Young LLP (EY US) today announced the release of its latest Technology Pulse Poll, which examines the impact of artificial intelligence (AI) on the future of work ?...



News published on and distributed by: